Hypoxic hepatitis

Liver International

Volumn 32, Issue 7, 2012, Pages 1039-1052

  Henrion, Jean ^a  

^a Hospital de Jolimont   (Belgium)

Author keywords

Hypoxic hepatitis; Ischaemic hepatitis; Shock liver

Indexed keywords

ANEMIA; ANOREXIA NERVOSA; AORTA ANEURYSM; BUDD CHIARI SYNDROME; CARDIOGENIC SHOCK; DISEASE COURSE; GRAND MAL EPILEPSY; HEART FAILURE; HEAT STROKE; HEMODYNAMICS; HEMORRHAGIC SHOCK; HEPATITIS; HUMAN; HYPOXIA; HYPOXIC HEPATITIS; INTENSIVE CARE UNIT; LEG ISCHEMIA; LIVER BLOOD FLOW; LIVER ISCHEMIA; MORTALITY; PATHOGENESIS; PREVALENCE; PROGNOSIS; RENDU OSLER WEBER DISEASE; RESPIRATORY FAILURE; REVIEW; SEPTIC SHOCK; SICKLE CELL ANEMIA; SLEEP APNEA SYNDROME;

ANOXIA; FEMALE; HEMODYNAMICS; HEPATITIS; HUMANS; MALE; PREVALENCE; PROGNOSIS; SHOCK; TRANSAMINASES;

EID: 84863525767     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02655.x     Document Type: Review

References (145)

1. Mallory FB. Necroses of the liver. J Med Res 1901; 6: 264-80.
2. Henrion J, Schapira M, Luwaert R, et al. Hypoxic hepatitis. Clinical and hemodynamic study in 142 consecutive cases. Medicine 2003; 82: 392-406.
3. Birrer R, Takudan Y, Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 2007; 46: 1063-70.
4. Henrion J, Luwaert R, Colin L, et al. Hépatite hypoxique - Etude prospective, clinique et hémodynamique de 45 épisodes. Gastroenterol Clin Biol 1990; 14: 836-41.
5. Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009; 35: 1397-405.
6. Fuhrmann V, Jäger B, Zubkova A, Droly A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010; 122: 129-39.
7. Raurich JM, Llompart-Pou JA, Ferreruela M, et al. Hypoxic hepatitis in critically ill patients: incidence, etiology and risk factors for mortality. J Anesth 2011; 25: 50-6.
8. Mallory FB. Chronic passive congestion of the liver. J Med Res 1911; 24: 455-62.
9. Lambert RA, Allison BR. Types of lesion in chronic passive congestion of the liver. Bull Johns Hopkins Hosp 1916; 27: 350-6.
10. Ladue JS, Wroblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science 1954; 120: 497-9.
11. Wroblewski F, Jervis G, Ladue JS. The diagnostic prognostic and epidemliologic significance of serum glutamic oxaloacetic transaminase (SGO-T) alteration in acute hepatitis. Ann Intern Med 1956; 45: 782-800.
12. Chinsky M, Sherry S. Serum transaminase as a diagnostic aid. Arch Intern Med 1957; 99: 556-67.
13. Fragge RG, Kopel FB, Iglaver A. Serum glutamic oxalacetic transaminase (SGO-T) in congestive heart failure. Clinical study and review of the literature. Ann Intern Med 1960; 52: 1042-49.
14. Killip T III, Payne AM. High serum transaminase activity in heart disease. Circulation 1960; 21: 646-60.
15. Richman SH, Delman AJ, Grob D. Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med 1961; 30: 211-25.
16. Birgens HS, Henriksen J, Matzen P, Poulsen H. The shock liver. Acta Med Scand 1978; 204: 417-21.
17. Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci 1979; 24: 129-35.
18. Arcidi JM, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction. A clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 1981; 104: 159-66.
19. Henderson JM, Fales FW. Continuous flow fluorometry of low galactose concentration in blood or plasma. Clin Chem 1980; 26: 282-5.
20. Chang JP, Tan C-K. Serum albumin and male gender are independant predictors of mortality in patients with hypoxic hepatitis and can be used in a prognostic model to predict early in-patient mortality. Hepatology 2008; 48(Suppl): 447A.
21. Johnson RD, O'connor ML, Kerr RM. Extreme serum elevations of aspartate aminotransferase. Am J Gastroenterol 1995; 90: 1244-5.
22. Whitehead HW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 1999; 45: 129-33.
23. Bruguera M, Barrera JM, Corradi F, Mas A. Hipertransaminemia superior a 400 U/L en adultos atendidos en un hospital terciaro. Estudio propectivo de su etiologia. Gastroenterol Hepatol 2005; 28: 15-9.
24. Hickman PE, Potter JM. Mortality associated with ischaemic hepatitis. Aust N Z J Med 1990; 20: 32-4.
25. Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis. Clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998; 26: 183-6.
26. Henrion J, Descamps O, Luwaert R, et al. Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 1994; 21: 696-703.
27. Henrion J, De Maeght S, Schapira M, et al. Hypoxic hepatitis: a difficult diagnosis when the cardiomyopathy remains unrecognized and the course of liver enzyme follows an atypical pattern. A report of two cases. Acta Gastroenterol Belg 1998; 61: 385-9.
28. Myers JD, Hickam JB. An estimation of the hepatic blood flow and splanchnic oxygen consumption in heart failure. J Clin Invest 1948; 27: 620-7.
29. Riddez L, Hahn RG, Brismar B, et al. Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med 1997; 25: 635-40.
30. Ruokonen E, Takala J, Kari A. Regional blood flow and oxygen transport in patients with the low cardiac output syndrome after cardiac surgery. Crit Care Med 1992; 21: 1304-11.
31. Spapen H. Liver perfusion in sepsis, septic shock and multiorgan failure. Anat Rec 2008; 29: 714-20.
32. Laut WW. Hepatic vasculature: a conceptual review. Gastroenterology 1981; 81: 159-73.
33. Laut WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985; 249: G549-56.
34. Ballet F. Hepatic circulation: potential for therapeutic intervention. Pharmacol Ther 1190; 47: 281-328.
35. Jacobsen KR, Ranek L, Tygstrup N. Liver function and blood flow in normal man during infusion of vasopressin. Scand J Clin Lab Invest 1969; 24: 279-84.
36. Shoemaker WC. Relation of oxygen transport patterns to the pathophysiology and therapy of shock states. Intensive Care Med 1987; 13: 230-43.
37. Creamer JE, Edwards JD, Nightingale P. Hemodynamic and oxygen transport variables in cardiogenic shock secondary to acute myocardial infarction, and response to treatment. Am J Cardiol 1990; 65: 1297-300.
38. Shibutani K, Komatsu T, Kubal K, et al. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983; 11: 640-3.
39. Villar J, Slutsky AS, Hew E, Aberman A. Oxygen transport and oxygen consumption in critically ill patients. Chest 1990; 98: 687-92.
40. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000; 109: 109-13.
41. Cohen J, Kaplan M. Left-sided heart failure presenting as hepatitis. Gastroenterology 1978; 74: 583-7.
42. Henrion J, Minette P, Colin L, et al. Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 cases. Hepatology 1999; 29: 427-33.
43. Ucgun I, Ozakyol A, Metintas M, et al. Relationship between hypoxic hepatitis and cor pulmonale in patients treated in the respiratory ICU. J Clin Pract 2005; 59: 1295-300.
44. Dahn MS, Wilson RF, Lange P, Stone A, Jacobs LA. Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis. Surgery 1990; 107: 295-301.
45. Takala J, Ruokonen E. Blood flow and oxygen transport in septic shock. Clin Intensive Care 1992; 3(Suppl to number 1): 24-7.
46. Hanneman L, Meier-Hellemann A, Reinhart K. Regional blood flow in sepsis. Clin Intensive Care 1992; 3(Suppl to number 2): 54-8.
47. Edwards JD. Oxygen transport in cardiogenic and septic shock. Crit Care Med 1991; 19: 658-63.
48. Zhang H, Vincent J-L. Oxygen extraction is altered by endotoxin during tamponade-induced stagnant hypoxia in the dog. Circ Shock 1993; 40: 168-76.
49. 2 uptake during endotoxemia. J Appl Physiol 1988; 64: 2410-19.
50. Henrion J, Schapira M, Ghilain J-M, et al. Upper gastrointestinal bleeding: what has changed during the last 20 years? Gastroenterol Clin Biol 2008; 32: 839-47.
51. Jaeschke H, Farhood A. Neutrophils and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: G355-62.
52. Henrion J. Ischemia/Reperfusion injury of the liver: pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. Acta Gastroenterol Belg 2000; 63: 336-47.
53. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-57.
54. Wilson WC, Macgregor AR, Stewart CP. The clinical course and pathology of burns and scolds under modern methods of treatment. Br J Surg 1938; 25: 826-65.
55. Bywaters EG. Anatomical changes in the liver after trauma. Am J Pathol 1948; 26: 19-39.
56. Mallory TB, Sullivan ER, Burnett CH, et al. The general pathology of traumatic shock. Surgery 1950; 27: 629-44.
57. Ellenberg M, Osserman KE. The role of shock in the production of central liver cell necrosis. Am J Med 1951; 11: 170-8.
58. Brunson JG, Eckman PL, Campbell JB. Increasing prevalence of unexplained liver necrosis. N Engl J Med 1957; 257: 52-6.
59. De La Monte SM, Arcidi JM, Moore GW, Hutchins GM. Midzonal necrosis as a pattern of hepatocellular injury after shock. Gastroenterology 1984; 86: 627-31.
60. Marotto ME, Thurman RG, Lemasters JJ. Early midzonal cell death during low-flow hypoxia in the isolated, perfused rat liver: protection by allopurinol. Hepatology 1988; 8: 585-90.
61. Suematsu M, Suzuki H, Ishii H, et al. Early midzonal oxidative stress preceding cell death in hypoperfused rat liver. Gastroenterology 1992; 103: 994-1001.
62. Cassidy WM, Reynolds TB. Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol 1994; 19: 118-21.
63. Garland JS, Werlin SL, Rice TB. Ischemic hepatitis in children: diagnosis and clinical course. Crit Care Med 1988; 16: 1209-12.
64. Jacqmin E, Saliba E, Blond MH, Chautepie A, Laugier J. Liver dysfunction and acute cardiocirculatory failure in children. Eur J Pediat 1992; 151: 731-4.
65. Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol 1992; 87: 831-6.
66. Wallach HF, Popper H. Central necrosis of the liver. Arch Pathol 1950; 49: 33-42.
67. Gore RM, Mathieu DG, White EM, et al. Passive hepatic congestion: cross-sectional imaging features. A J R 1994; 162: 71-5.
68. Holley H, Koslin B, Berland L, Stanley RJ. Inhomogeneous enhancement of liver parenchyma secondary to passive congestion: contrast-enhanced CT. Radiology 1989; 170: 795-800.
69. Henriksson L, Hedman A, Johansson R, Lindstrom K. Ultrasound assessment of liver veins in congestive heart failure. Acta Radiol 1982; 23: 361-3.
70. Jenkins JG, Lynn AM, Wood AE, Trusler GA, Barker GA. Acute hepatic failure following cardiac operation in children. J Thorac Cardiovasc Surg 1982; 84: 865-71.
71. Matsuda H, Covino E, Hirose H, et al. Acute liver dysfunction after modified Fontan operation for complex cardiac lesions. J Thorac Cardiovasc Surg 1988; 96: 219-26.
72. Henrion J, Colin L, Schmitz A, Schapira M, Heller FR. Ischemic hepatitis in cirrhosis. Rare but lethal. J Clin Gastroenterol 1993; 16: 35-9.
73. Pauwels A, Levy VG. Ischemic hepatitis in cirrhosis: not so rare, not always lethal. J Clin Gastroenterol 1993; 17: 88-9.
74. Henrion J, Hautekeete M, Brenard R, et al. Insuffisance hépatocellulaire fulminante ou subfulminante secondaire à une infiltration métastatique du foie: une autre cause d'hépatite hypoxique? Gastroenterol Clin Biol 1996; 20: 535-43.
75. Harrison HB, Middleton HM III, Grosby JH, Dasher N. Fulminant hepatic failure, an unusual presentation of metastatic liver disease. Gastroenterology 1981; 80: 820-5.
76. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002; 346: 1978-88.
77. Yeo TP. Heat stroke. A comprehensive review. AACN Clin Issues 2004; 15: 280-93.
78. Hassanein T, Perpeg J, Tepperman L, Starzl TE, Vanthiel DH. Liver failure occurring as a component of excertional heatstroke. Gastroenterology 1991; 100: 1442-7.
79. Hassanein T, Razack A, Gavaler JS, Vanthiel DH. Heat stroke: its clinical and pathological presentation, with particular attention to the liver. Am J Gastroenterol 1992; 87: 1382-9.
80. Garcin JM, Bronstein JA, Cremades S, Courbin P, Cointet F. Acute liver failure is frequent during heat stroke. World J Gastroenterol 2008; 7: 158-9.
81. Takahashi K-I, Chin K, Ogawa K, et al. Living donor liver transplantation with noninvasive ventilation for exertional heat stroke and severe rhabdomyolysis. Liver Transpl 2005; 11: 570-2.
82. Nahamud N, Haymaker W, Custer P. Heat stroke. A clinico-pathologic study of 125 fatal cases. Milit surgeon 1946; 99: 397-449.
83. Rubel LR, Ishak KG. The liver in fatal exertional heatstroke. Liver 1983; 3: 249-60.
84. Yan Y-E, Zhao Y-P, Wang H, Fan M. Pathophysiological factors underlying heat stroke. Med Hypotheses 2006; 67: 609-17.
85. Green AR, O'shea E, Colado MI. A review of the mechanisms involved in the acute MDHA (Ectasy)- induced hyperthermic response. Eur J Pharmacol 2004; 500: 3-13.
86. Berry P, Cross T, Thain SL, et al. Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clinic Gastroenterol Hepatol 2007; 5: 1469-76.
87. Charlotte F, Bachir D, Nenert M, et al. Vascular lesions of the liver in sickle cell disease. A clinicopathological study in 26 living patients. Arch Pathol Lab Med 1995; 119: 46-52.
88. Ichai P, Huguet E, Guettier C, et al. Fulminant hepatitis after grand mal seizures: mechanisms and role of liver transplantation. Hepatology 2003; 38: 443-51.
89. Okas A, Kowalezyk J, Stein R, Lee D, Berkelhammer C. Hypoxic hepatitis related to profound anemia: how low can you go? Am J Gastroenterol 2001; 96: 3445-7.
90. Blich H, Edelstein S, Mansano R, Edoute Y. Ischemic hepatitis induced by severe anemia. Isr Med Assoc J 2003; 5: 208-9.
91. Mathurin P, Durand F, Ganne N, et al. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995; 109: 1682-4.
92. Henrion J, Colin L, Schapira M, Heller FR. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997; 24: 245-9.
93. Trakada G, Gogos C, Tsiamita M, et al. A case of ischemic hepatitis. Sleep Breath 2004; 8: 155-9.
94. Di Pascoli L, Lion A, Milazzo O, Caregaro L. Acute liver damage in anorexia nervosa. Int J Eat Disord 2004; 36: 114-7.
95. De Caprio C, Alfano A, Senatore I, et al. Severe acute liver damage in anorexia nervosa: two case reports. Nutrition 2006; 22: 572-5.
96. Dowman J, Arulraj R, Chesner I. Recurrent acute hepatic dysfunction in severe anorexia nervosa. Int J Eat Disord 2010; 43: 770-2.
97. Rautou P-E, Cazals-Hatem D, Moreau R, et al. Acute liver damage in patients with anorexia nervosa. A possible role of starvation-induced hepatocyte autophagy. Gastroenterology 2008; 135: 840-5.
98. Ohwada R, Hotta M, Kimura H, et al. Ampulla cardiomyopathy after hypoglycemia in three young female patients with anorexia nervosa. Intern Med 2005; 44: 228-33.
99. Rautou PE, Mansouri A, Lebrec D, et al. Autophagy in liver diseases. J Hepatol 2010; 53: 1123-34.
100. Levy PJ, Tabares AH, Olin JW, et al. Disseminated intravascular coagulation associated with acute ischemic hepatitis after elective aortic anevrysm repair: comparative analysis of 10 cases. J Cardiothorax Vasc Anesth 1997; 11: 141-8.
101. Sobrinho G, Ferreira ME, Albino JP, Gomes H, Capitao LM. Acute ischemic hepatitis in aortocaval fistula. Eur J Vasc Endovasc Surg 2005; 29: 239-43.
102. Henrion J, Deltenre P, De Maeght S, Peny M-O, Schapira M. Acute lower limb ischemia as a triggering condition in hypoxic hepatitis: a study of 5 cases. J Clin Gastroenterol 2011; 45: 274-7.
103. Valla DC. Primary Budd-Chiari syndrome. J Hepatol 2009; 50: 195-203.
104. Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994; 73: 21-36.
105. Henrion J, Deltenre P, Peny M-O, et al. Fatal hypoxic hepatitis in a patient with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber's disease). Acta Gastroenterol Belg 2010; 73: 49-52.
106. Abbà GE, Gallitelli M, Pasculli G, et al. HHT: a rare disease with a broad spectrum of clinical aspects. Curr Pharmacol Des 2006; 12: 1217-20.
107. Gadeholt H, Haugen J. Centrilobular hepatic necrosis in cardiac failure. One case with severe acute jaundice. Acta Med Scand 1964; 176: 525-8.
108. Dutt MK. Deep jaundice due to congestive cardiomyopathy. Br J Clin Pract 1980; 34: 306-7.
109. Moussavian SN, Dincsoy HP, Goodman S, Helm RA, Bozian R. Severe hyperbilirubinemia and coma in chronic congestive heart failure. Dig Dis Sci 1982; 27: 175-80.
110. Escorsell A, Mas A, De La Mata M. and the Spanish group for the Study of Acute Liver Failure. Liver Transpl 2007; 13: 1389-95.
111. Wei G, Bergquist A, Broome U, et al. Acute Liver failure in Sweden: etiology and outcome. J Int Med 2007; 262: 393-401.
112. Lee W. Etiologies of acute liver failure. Semin Liver Dis 2008; 28: 142-52.
113. Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl 2008; 14: S67-79.
114. Fuhrmann V, Kneidingen N, Herkner H, et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 2011; 37: 1302-10.
115. Nouel O, Henrion J, Bernuau J, et al. Fulminant hepatic failure due to transient circulatory failure in patients with chronic heart disease. Dig Dis Sci 1980; 25: 49-52.
116. Denis C, De Kerguennec C, Bernuau J, Beauvois F, Cohen Solal A. Acute hypoxic hepatitis (« liver shock »): still a frequently overlooked cardiological diagnosis. Eur J Heart Fail 2004; 6: 561-5.
117. Ebert E. Hypoxic liver injury. Mayo Clin Proc 2006; 81: 1232-36.
118. Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis 2002; 6: 947-67.
119. Khandelwal N, James LP, Sanders C, et al. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology 2011; 53: 567-76.
120. Duckro AN, Sha BE, Jakate S, et al. Herpes simplex virus hepatitis: expanding the spectrum of disease. Transpl Infect Dis 2006; 8: 171-6.
121. Norvell JP, Blei AT, Jovanovic BD, Levitsky J. Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl 2007; 13: 1428-34.
122. Ander DS, Jaggi M, Rivers E, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998; 82: 888-91.
123. Treem WR, Boyle JT. Severe cardiomyopathy simulating hepatitis in adolescence. Clin Pediatr 1986; 25: 260-5.
124. Seeley TT, Blumenfeld CH, Ikeda R, Knapp W, Ruebner BH. Hepatic infarction. Hum Pathol 1972; 3: 265-76.
125. Miura F, Asano T, Amano H. Eleven cases of postoperative hepatic infarction following pancreato-biliary surgery. J Gastrointest Surg 2010; 14: 352-8.
126. Leu-Toaff AS, Friedman AG, Cohen L, Radecki PD, Caroline DF. Hepatic infarcts: new observations by CT and sonography. A J R 1987; 149: 87-90.
127. Rokke O, Nesuik I, Sondena A. Traumatic and postoperative ischemic liver necrosis: causes, risk factors and treatment. Dig Surg 2000; 17: 595-601.
128. Van Glinski S, Krettek C, Blauth M, Oldhafer K-J. Hepatic ischemia as a complication after correction of post-traumatic gibbus at the thoracolumbar junction. Spine 2000; 25: 1040-4.
129. Brienza N, Dalfino L, Cinnella G, et al. Jaundice in critical illness. Promoting factors of a concealed reality. Intensive Care Med 2006; 32: 267-74.
130. Bansol V, Schuchert VD. Jaundice in the intensive care unit. Surg Clin N Am 2006; 86: 1495-502.
131. Schmid M, Hefti ML, Gattiker R, Kistler HJ, Senning A. Benign postoperative intrahepatic cholestasis. N Engl J Med 1965; 272: 545-50.
132. Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care 1991; 19: 165-181.
133. Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 574-85.
134. Larcan A, Lambert H, Rauber G, Laprevote-Heully H-C, Delorme N. L'atteinte hépatique au cours des états de choc ("foie de choc"). Gastroenterol Clin Biol 1979; 3: 105-18.
135. Strassburg CP. Shock liver. Best Pract Res Clin Gastroenterol 2003; 17: 369-81.
136. Gelbmann CM, Rummele P, Wimmer M, et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 2007; 102: 1221-9.
137. Zilkens C, Friese J, Köller M, Muhr G, Schinkel C. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis. Eur J Med Res 2008; 13: 309-13.
138. Raurich JM, Perez O, Llompart-Pou JA, et al. Incidence and outcome of ischemic hepatitis complicating septic shock. Hepatol Res 2009; 39: 700-5.
139. Dubin A, Estenssoro E, Murios G, et al. Effects of haemorrhage on gastrointestinal oxygenation. Intensive Care Med 2001; 27: 1931-6.
140. Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci 2006; 11: 520-8.
141. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
142. Asfar P, De Bakker D, Meier-Hellemann A, Radermacker P, Sakka SG. Clinical review: influence of Vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care Med 2004; 8: 170-9.
143. Reinelt H, Radermacker P, Fischer G, et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997; 86: 818-24.
144. Kram HB, Evans T, Bundage B, Shoemaker WC. Use of dobutamine for treatment of shock liver syndrome. Crit Care Med 1988; 16: 644-5.
145. Thoresen SD, Mark SJ, Hartveit F. Mock hepatitis. Lancet 1980; I: 36.